This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
She also has a hx of paroxysmal atrialfibrillation and is on oral anticoagulant treatment. She had a single chamber ICD/Pacemaker implanted several years prior due to ventricular tachycardia. Answer : The ECG above shows a regular wide complex tachycardia. Cardiac output (CO) was being maintained by the tachycardia.
Volta Medical has announced it has entered into a Joint Development Agreement with GE Healthcare to enhance arrhythmia procedures with artificial intelligence (AI)-driven electrophysiology technologies. Estimates of current and future incidence and prevalence of atrialfibrillation in the U.S. adult population.
The ECGs show a wide complex, irregularly irregular tachycardia. The differential of wide complex irregularly irregular includes: polymorphic VT, atrialfibrillation with WPW, atrialfibrillation with other aberrancy. Thus, the patients rhythm is atrialfibrillation with WPW.
The trial will evaluate the outcomes of therapy provided with the FARAPULSE PFA System versus AADs, including device-or procedure-related adverse events, the rates of freedom from AF, atrial flutter, or atrialtachycardia, as well as AF burden – a measurement of the amount of AF an individual experiences. Circulation.
Epicardial Marshall bundle (MB) are frequently utilized in left atrialtachycardias (LATs) post atrialfibrillation (AF) ablation with pulmonary vein isolation and substrate modification.
However, widely split P' waves in focal atrialtachycardia (AT) on a surface electrocardiogram (ECG) have rarely been reported. The electrophysiological mechanism is relatively difficult to clarify, requiring a electrophysiological study. P' waves were markedly prolonged in duration and widely split in morphology.
The two ECGs above were texted to me with the text: "Young Guy came in in SVT but now in and out of irregular wide complex tachycardia. -- not sure if polymorphic VT vs. a fib with WPW." Definitely atrialfibrillation. Probably WPW but is very slow for atrial fib withWPW. So this looks like WPW with Atrialfibrillation.
Whenever it is this fast, you need to be very careful to ascertain whether it is irregular ( as in atrialfibrillation with rapid ventricular respsonse ) or regular ( as in VT ). This is not because it is polymorphic VT; it is because it is WPW with atrialfibrillation. Smith : What do you think? It is not VT; it is AF.
Abstract Introduction Some previous studies have reported that a first-step ethanol infusion into the vein of Marshall (EIVOM) with touch-up radiofrequency (RF) ablation can facilitate mitral isthmus (MI) block and improves the ablation outcomes in persistent atrialfibrillation (PeAF) patients. 0.78, p = .006).
Backgroundwide antral pulmonary vein isolation (PVI) is effective for treating paroxysmal atrialfibrillation (PAF), although time-demanding. Procedural data and electrophysiology (EP) laboratory times were systematically collected and analyzed.
Abstract Introduction Atrialfibrillation and atrial flutter originating from the donor s heart is a commonly reported complication post heart transplant. Case A 47-year-old male presented with atrialtachycardia 6 months post heart transplant.
Studies have shown that mutations in the RYR2 gene, which encodes the RyR2 protein, are linked to several cardiac arrhythmias, including catecholaminergic polymorphic ventricular tachycardia (CPVT), long QT syndrome (LQTS), calcium release deficiency syndrome (CRDS), and atrialfibrillation (AF).
Procedures were most commonly for atrialfibrillation (52.4%), atrial flutter (10.9%), and atrioventricular nodal re-entrant tachycardia (10.1%). Results 1089 patients were included: MC 718 (65.9%); Fo8 HT 105 (9.6%); Fo8 MOD 266 (24.4%). 01; minor: MC 16.5%, Fo8 HT 12.0%, Fo8 MOD 7.4%, p =.002).
1 Catheter ablation for atrialfibrillation (AF) and ventricular tachycardia (VT) has become the standard of care for many patients presenting with these arrhythmias.2–4 In the past decade, major advances were made in catheter ablation for arrhythmias and implantation of cardiac implantable electronic devices.1
Circulation: Arrhythmia and Electrophysiology, Ahead of Print. BACKGROUND:Inflammation may promote atrialfibrillation (AF) recurrence after catheter ablation. mg twice daily or placebo for 10 days. mg twice daily or placebo for 10 days. The first dose of the study drug was administered within 4 hours before ablation.
This measurement has been correlated with those made at electrophysiology study and may predict the potential risk of rapid anterograde conduction if the person develops atrialfibrillation. Bidirectional ventricular tachycardia is the classical arrhythmia noted in catecholaminergic polymorphic ventricular tachycardia.
The advent of transseptal puncture has enabled the study of atrialfibrillation mechanisms, while epicardial access has enabled exploration of the epicardium in ventricular arrhythmias (ventricular tachycardia/ventricular fibrillation [VF]).1,2
Abstract Introduction Despite advanced ablation strategies and major technological improvements, treatment of persistent atrialfibrillation (AF) remains challenging and the underlying pathophysiology is not fully understood. ms after) and AF termination to atrialtachycardia (AT) or sinus rhythm (SR) in 12 patients (24%).
Abstract Introduction The use of flecainide and propafenone for medical cardioversion of atrialfibrillation (AF) and atrial flutter/intra-atrial reentrant tachycardia (IART) is well-described in adults without congenital heart disease (CHD).
FAAM ablation successfully decreased the recurrence rate of atrial tachyarrhythmia compared with conventional non-PV foci ablation. Abstract Introduction Treatment of recurrent atrialfibrillation (AF) is sometimes challenging due to non-pulmonary vein (PV) foci. The RHYTHMIA system was used to perform all the procedures.
Abstract Background Dofetilide is a class III antiarrhythmic agent approved for the treatment of atrialfibrillation and atrial flutter. Given the efficacy of other class III agents, it has been used off-label for the treatment of premature ventricular complexes (PVCs) and ventricular tachycardias (VTs).
Abstract Introduction It would be helpful in determining ablation strategy if the occurrence of perimitral atrialtachycardia (PMAT) could be predicted in advance. We calculated their E-PMCT.
Wolff-Parkinson-White syndrome (WPW) was most prevalent at 31%, followed by atrioventricular nodal reentrant tachycardia (AVNRT) at 24%, atrioventricular reentrant tachycardia (AVRT) at 16%, ventricular tachycardia (VT) at 10%, atrialfibrillation (AF) at 3%, and atrialtachycardia (AT) at 1%.
Methods and Results This case report discusses a 65-year-old man who had previously undergone pulmonary vein isolation (PVI) and cavo-tricuspid isthmus ablation for atrialfibrillation before ASD closure, respectively. He developed atrialtachycardia (AT) and underwent catheter ablation.
This is mainly to account for the individual variation in anatomical location of right ventricular outflow tract, the main location of electrophysiological abnormalities in Brugada syndrome. If three or more extra stimuli are needed for induction of ventricular fibrillation, the importance comes down further. mV or R/q ≥ 0.75.
ABSTRACT Introduction The tissue temperature-controlled DiamondTemp ablation (DTA) catheter has been mainly used for atrialfibrillation ablation. Methods Twenty patients were studied: 10 with right ventricular outflow tract PVCs/VTs, eight with PVCs/VTs from the aortic sinus cusps, and two with left ventricular outflow tract PVCs.
Although the QDOT MICRO™ Catheter was mainly designed for pulmonary vein isolation (PVI) its versatility to treat atrialfibrillation (AF) and other types of arrhythmias was recently evaluated by the FAST and FURIOUS study series and other studies and will be presented in this article.
ECG data during the clinical arrhythmia (ventricular tachycardia [VT], upper left figure) is analyzed with an artificial intelligence algorithm which identifies a probable location of the source of the arrhythmia (left ventricular anterolateral papillary muscle, lower left figure). cm, LVEF 50 ± 18%) and was similar to 28 controls.
The ECG there reportedly showed an irregular tachycardia, and the patient was immediately referred to the emergency room. Here is her ECG on arrival: There is a wide complex tachycardia that is irregularly irregular (this is difficult to determine at these very high rates). Lead aVR seems to show the atrial activity clearly.
Objective This study compared procedural and outcome data for PFA-PVI to VHPSD-PVI in patients with paroxysmal or persistent atrialfibrillation (PAF/persAF). Compared to PFA VHPSD-PVI might ensure information on left atrial substrate allowing to target concomitant secondary tachycardias.
There is atrialfibrillation. Comments: STEMI with hypokalemia, especially with a long QT, puts the patient at very high risk of Torsades or Ventricular fibrillation (see many references, with abstracts, below). See here for management of Polymorphic Ventricular Tachycardia , which includes Torsades.
ABSTRACT Introduction The safety and efficacy of paroxysmal atrialfibrillation (PAF) ablation with the HELIOSTAR multielectrode radiofrequency (RF) balloon catheter have been demonstrated in European studies; data from elsewhere are lacking. Central Illustration. Image is courtesy of Biosense Webster, Inc., All rights reserved.
a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech , today announced European CE mark approval of the VARIPULSE Platform for the treatment of symptomatic drug refractory recurrent paroxysmal atrialfibrillation ( AF ) using pulsed field ablation (PFA). AtrialFibrillation. Circulation.
Circulation: Arrhythmia and Electrophysiology, Ahead of Print. BACKGROUND:Patients undergoing first-time atrialfibrillation (AF) ablation can benefit from targeting non-pulmonary vein (PV) triggers. Preprocedural identification of high-risk individuals can guide planning of ablation strategy.
ABSTRACT Background Catheter ablation (CA) for atrialfibrillation (AF) in the elderly poses a growing challenge. Methods Octogenarians with AF or consecutive atrialtachycardia undergoing index or re-ablation (pulmonary vein isolation [PVI] and ablation beyond PVI with different energy sources) in a single center, were analyzed.
Abstract Introduction Pulsed field ablation (PFA) is a new ablation technology for atrialfibrillation (AF). Data regarding early recurrences of atrial tachyarrhythmia (ERAT) after PFA-pulmonary vein isolation (PVI) are sparse. We found no difference in the rate of LRs among patients experiencing ERAT before or after 45 days.
Here was his ED ECG: There is sinus tachycardia (rate about 114) with nonspecific ST-T abnormalities. There is a large peaked P-wave in lead II (right atrial enlargement) There is left axis deviation consistent with left anterior fascicular block. See my quick review of atrialtachycardia below) The tachycardia spontaneously resolved.
For right or wrong reasons, the world of electrophysiology has pushed us into a belief system that, if it is AF, the culprit must be pulmonary veins. It doesn’t require any extraordinary intelligence to conclude any chronic focal atrialtachycardia can get degenerated to AF in the long run. It is still true in many cases.
Additionally, the patient had no other apparent reason to have sinus tachycardia (such as volume depletion, bleeding, fever). So the most likely rhythm in ECG 1 is ectopic atrialtachycardia. Therefore the first part of ECG 1 shows ectopic atrialtachycardia with biventricular pacing. Point 1: What is PVARP?
If the patient has Abnormal Vital Signs (fever, hypotension, tachycardia, or tachypnea, or hypoxemia), then these are the primary issue to address, as there is ongoing pathology which must be identified. Electrophysiologic studies were performed in selected patients only as clinically appropriate.
ABSTRACT Introduction Freedom from recurrences of atrial tachyarrhythmia (ATA) is suboptimal after pulmonary vein isolation (PVI) in patients with persistent atrialfibrillation (PsAF).
ABSTRACT Typical atrial flutter (AFL), defined as cavotricuspid isthmus (CTI)-dependent macro-re-entrant atrialtachycardia, often causes debilitating symptoms, and is associated with increased incidence of atrialfibrillation, stroke, heart failure, and death.
Results Among 541 participants, 93% were diagnosed with WPW syndrome, with orthodromic atrioventricular reciprocating tachycardia (AVRT) being the most prevalent arrhythmia, affecting 55% of the cases. Electrical cardioversion was the first-line treatment for pre-excited atrialfibrillation and antidromic AVRT across all of Africa.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content